Société biopharmaceutique de recherche axée sur l'inflammation et l'oncologie.
| Date | Déclarant | Émetteur | Nb | Prix | Total | |
|---|---|---|---|---|---|---|
| Baker Daniel George Action |
GALAPAGOS | 363 | 43€ | 15486€ | ||
| Svanberg Elisabeth Action |
GALAPAGOS | 532 | 43€ | 22695€ | ||
| Schaffert Susanne Antonie Action |
GALAPAGOS | 360 | 36€ | 12896€ | ||
| Contamine Jérôme Action |
GALAPAGOS | 644 | 36€ | 23070€ | ||
| Sturge Simon John Action |
GALAPAGOS | 180 | 36€ | 6448€ | ||
| Guenter Peter Action |
GALAPAGOS | 644 | 36€ | 23070€ | ||
| Svanberg Elisabeth Action |
GALAPAGOS | 635 | 36€ | 22736€ | ||
| Baker Daniel George Action |
GALAPAGOS | 635 | 36€ | 22736€ | ||
| Stoffels IMC Autre |
GALAPAGOS | 18 | 35€ | 647536€ | ||
| Missotten Annelies Action |
GALAPAGOS | 2 | 34€ | 89284€ | ||
| EcoR1 Capital Fund Qualified, L.P. ADR / ADS |
GALAPAGOS | 89 | 33€ | 2977320€ | ||
| EcoR1 Capital Fund, L.P. ADR / ADS |
GALAPAGOS | 6 | 33€ | 210727€ | ||
| EcoR1 Capital Fund Qualified, L.P. ADR / ADS |
GALAPAGOS | 127 | 32€ | 4111080€ | ||
| EcoR1 Capital Fund, L.P. ADR / ADS |
GALAPAGOS | 8 | 32€ | 290983€ | ||
| EcoR1 Capital Fund, L.P. ADR / ADS |
GALAPAGOS | 16 | 30€ | 506613€ | ||
| EcoR1 Capital Fund Qualified, L.P. ADR / ADS |
GALAPAGOS | 235 | 30€ | 7157870€ | ||
| Johnston Neil Action |
GALAPAGOS | 137 | 29€ | 3950€ | ||
| Griffiths Jane Action |
GALAPAGOS | 378 | 29€ | 10899€ | ||
| Contamine Jérôme Action |
GALAPAGOS | 1559 | 29€ | 44953€ | ||
| EcoR1 Capital Fund Qualified, L.P. ADR / ADS |
GALAPAGOS | 58 | 29€ | 1681760€ | ||
| EcoR1 Capital Fund, L.P. ADR / ADS |
GALAPAGOS | 3 | 29€ | 112300€ | ||
| EcoR1 Capital Fund, L.P. ADR / ADS |
GALAPAGOS | 956 | 29€ | 27540€ | ||
| EcoR1 Capital Fund Qualified, L.P. ADR / ADS |
GALAPAGOS | 14 | 29€ | 412554€ | ||
| Svoronos Dawn Action |
GALAPAGOS | 375 | 29€ | 10785€ | ||
| Hoekema Andre Action |
GALAPAGOS | 5 | 29€ | 143750€ |